Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pane

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Leukemia|August 13, 2010
Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formationJ Score, M J Calasanz, O Ottman, et al.
Radiology Case Reports|April 9, 2019
Delivery of selective internal radiation therapy complicated by variant hepatic vascular anatomyA Paladini, G E Vallati, D Beomonte Zobel, et al.
Annals of Hematology|April 28, 2021
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trialM Picardi, C Cavaliere, R Della Pepa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 3, 2017
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paperL Sarmati, M Andreoni, G Antonelli, et al.
Haematologica|March 20, 2001
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemiaM Amabile, B Giannini, N Testoni, et al.
Annals of Hematology|June 26, 2020
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patientsSalvatore Palmieri, S Rocco, O Vitagliano, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
Bone Marrow Transplantation|November 18, 2014
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMTM Hengeveld, S Suciu, Y Chelgoum, et al.
Leukemia|September 18, 2009
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patientsI Iacobucci, A Lonetti, F Messa, et al.
Leukemia|February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaN C P Cross, H E White, D Colomer, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Leukemia|August 13, 2010
Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formationJ Score, M J Calasanz, O Ottman, et al.
Radiology Case Reports|April 9, 2019
Delivery of selective internal radiation therapy complicated by variant hepatic vascular anatomyA Paladini, G E Vallati, D Beomonte Zobel, et al.
Annals of Hematology|April 28, 2021
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trialM Picardi, C Cavaliere, R Della Pepa, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 3, 2017
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paperL Sarmati, M Andreoni, G Antonelli, et al.
Haematologica|March 20, 2001
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemiaM Amabile, B Giannini, N Testoni, et al.
Annals of Hematology|June 26, 2020
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patientsSalvatore Palmieri, S Rocco, O Vitagliano, et al.
Leukemia|May 18, 2007
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemiaD Cilloni, F Messa, G Martinelli, et al.
Bone Marrow Transplantation|November 18, 2014
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMTM Hengeveld, S Suciu, Y Chelgoum, et al.
Leukemia|September 18, 2009
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patientsI Iacobucci, A Lonetti, F Messa, et al.
Leukemia|February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaN C P Cross, H E White, D Colomer, et al.
Pageof 9